N. Debzi

ORCID: 0000-0003-0842-1582
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Hepatitis C virus research
  • Inflammatory Bowel Disease
  • Organ Transplantation Techniques and Outcomes
  • Celiac Disease Research and Management
  • Eosinophilic Esophagitis
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Bone Tumor Diagnosis and Treatments
  • Musculoskeletal synovial abnormalities and treatments
  • Organ Donation and Transplantation
  • Renal Diseases and Glomerulopathies
  • Pancreatitis Pathology and Treatment
  • Healthcare Systems and Practices
  • Tumors and Oncological Cases
  • Diet, Metabolism, and Disease
  • Trace Elements in Health
  • Biochemical and Molecular Research
  • Oral and Maxillofacial Pathology
  • Viral Infections and Outbreaks Research
  • Microscopic Colitis
  • Cancer Genomics and Diagnostics
  • Pleural and Pulmonary Diseases

Hôpital Mustapha Pacha
2012-2025

Heinrich Heine University Düsseldorf
2013

University of Algiers 3
2009

Universidad Complutense de Madrid
2009

ABB (Germany)
2008

10.1016/s2468-1253(23)00098-5 article EN ˜The œLancet. Gastroenterology & hepatology 2023-05-22

To assess the efficacy and safety of locally manufactured generic sofosbuvir-based direct-acting antivirals in treatment Hepatitis C virus (HCV) infected patients on maintenance hemodialysis. We have conducted a retrospective multicenter study including hemodialysis, treated with regimens between 01/01/2017 09/30/2021. Patients were for 12 or 24 weeks, sofosbuvir 400 mg + ledipasvir 90 3 times/week, times/week daclatasvir 60 mg/d, coformulation, times/week. Sustained virological response was...

10.1111/hdi.13198 article EN Hemodialysis International 2025-01-21

To assess the role of major risk factors for hepatocellular carcinoma (HCC) development in western part North Africa.A multicenter case control study was conducted Tunisia, Morocco and Algeria collaboration with Pasteur Institutes these countries. A total 164 patients HCC 250 subjects without hepatic diseases were included. Prevalences HBsAg, anti-hepatitis C virus (HCV) diabetes assessed. HCV HBV genotyping performed anti-HCV HBsAg positive patients.The mean age 62 ± 10 years old a 1.5 M:F...

10.4254/wjh.v3.i1.24 article EN cc-by-nc World Journal of Hepatology 2011-01-01

This study used the Global Burden of Disease data (2010-2021) to analyze rates and trends point prevalence, annual incidence, years lived with disability (YLDs) for metabolic dysfunction-associated steatotic liver disease (MASLD) in 204 countries. Total numbers age-standardized per 100,000 population MASLD YLDs were compared across regions countries by age, sex, sociodemographic index (SDI). Smoothing spline models evaluate relationship between burden SDI. Estimates reported uncertainty...

10.1016/j.jhepr.2024.101271 article EN cc-by-nc-nd JHEP Reports 2024-11-14

The Hepatic hydrothorax is a pleural effusion related to portal hypertension; its diagnosis and therapeutic management may be difficult. aims of this article are which follows: To gather the practices hepatogastroenterologists or pulmonologists practitioners regarding hepatic hydrothorax.Practitioners from 13 French- speaking countries were invited answer an online questionnaire on management.Five hundred twenty-eight (80% France) responded survey. 75% hepatogastroenterologists, 20%...

10.1186/s12876-023-02931-z article EN cc-by BMC Gastroenterology 2023-09-12

Algeria is the largest country of Africa, peopled with populations living a range traditional/rural and modern/urban lifestyles. The variations prevalence chronic active hepatitis care poorly known on Algerian territory. We conducted retrospective survey all patients (n = 998) referred to our institution in 2012 confirmed by us for an C. Half C virus (HCV) isolates were genotyped. Forty regions out 48 represented study. Three geographical clusters (Aïn-Temouchent/SidiBelAbbes, Algiers, large...

10.1002/jmv.24491 article EN Journal of Medical Virology 2016-02-09

Background Little is known about molecular characteristics of HBV strains circulating in Algeria and there are few data regarding HDV infection. Objectives The aim this study to describe the genetic diversity existing determine seroprevalence Study design Plasma samples from 134 patients were analyzed by enzyme immunoassay method for serological markers. Genotyping performed using direct sequencing followed phylogenetic analyses PreS1 R0 region genome respectively. Results gene was...

10.1002/jmv.25301 article EN Journal of Medical Virology 2018-08-31

Background. Published data regarding the real-life application of combination sofosbuvir/daclatasvir in Algeria are lacking. Therefore, we conducted an observational study to assess efficacy and safety this regimen Algerian patients with chronic hepatitis C. Methods. We carried out a multicentric, observational, open-label generic fixed-dose (FDC) included 100 all genotypes for 12 or 24 weeks treatment without ribavirin. The primary outcome was proportion sustained virologic response (SVR)...

10.1155/2023/8297332 article EN Journal of Clinical Pharmacy and Therapeutics 2023-09-01

Objectif: Etudier l'impact de l'information préalable des patient devant subir une FOGD en ce qui concerne leur anxiété, tolérance, satisfaction ainsi que la performance l'endoscopiste.

10.1055/s-2008-1066961 article FR Endoscopy 2008-03-07

colonoscopy).Two cases had jejunal apthous ulcers, and there was one case each of mild patchy TI erythema ulcers.Two-tailed Fisher's exact test revealed that the difference between these two groups also not statistically significant (p=1).Conclusions: The utility FC to diagnose small bowel CD remains debatable, with previous studies showing differing outcomes.In our cohort, levels did reliably correlate VCE findings.The correlation level diagnosis by significant.Based on findings, decision...

10.1093/ecco-jcc/jju027.274 article EN Journal of Crohn s and Colitis 2015-02-01
Coming Soon ...